CCNA2 and neoplasm: HULC induced tumor proliferation, migration and cell cycle progression by modulating the expression of Cyclin A/D1/E, p-Rb, c-Myc, CDK2/4, and p16/p21/27, which are targets of Skp-1/2 and inhibitors of CDK2/4 and EZH2.